The European Medicines Agency (EMA) is set to hold a press briefing in Amsterdam on Wednesday at 4 pm, on its review of possible links between AstraZeneca’s COVID-19 vaccine and blood clotting cases.
The press conference was officially confirmed on EU institutions’ website.
On Tuesday, EMA head of vaccine strategy Marco Cavaleri said it was clear that there was a link between the AstraZeneca jab and clots.